Association of genetic variants on 15q12 with cortical thickness and cognition in schizophrenia.

CONTEXT Cortical thickness is a highly heritable structural brain measurement, and reduced thickness has been associated with schizophrenia, bipolar disorder, and decreased cognitive performance among healthy control individuals. Identifying genes that contribute to variation in cortical thickness provides a means to elucidate some of the biological mechanisms underlying these diseases and general cognitive abilities. OBJECTIVES To identify common genetic variants that affect cortical thickness in patients with schizophrenia, patients with bipolar disorder, and controls and to test these variants for association with cognitive performance. DESIGN A total of 597 198 single-nucleotide polymorphisms were tested for association with average cortical thickness in a genome-wide association study. Significantly associated single-nucleotide polymorphisms were tested for their effect on several measures of cognitive performance. SETTING Four major hospitals in Oslo, Norway. PARTICIPANTS A total of 1054 case individuals and controls were analyzed in the genome-wide association study and follow-up cognitive study. The genome-wide association study included controls (n = 181) and individuals with DSM-IV -diagnosed schizophrenia spectrum disorder (n = 94), bipolar spectrum disorder (n = 97), and other psychotic and affective disorders (n = 49). MAIN OUTCOME MEASURES Cortical thickness measured with magnetic resonance imaging and cognitive performance as assessed by several neuropsychological tests. RESULTS Two closely linked genetic variants (rs4906844 and rs11633924) within the Prader-Willi and Angelman syndrome region on chromosome 15q12 showed a genome-wide significant association (P = 1.1 x 10(-8) with average cortical thickness and modest association with cognitive performance (permuted P = .03) specifically among patients diagnosed as having schizophrenia. CONCLUSION This genome-wide association study identifies a common genetic variant that contributes to the heritable reduction of cortical thickness in schizophrenia. These results highlight the usefulness of cortical thickness as an intermediate phenotype for neuropsychiatric diseases. Future independent replication studies are required to confirm these findings.

[1]  Shitij Kapur,et al.  Effect of Chronic Antipsychotic Treatment on Brain Structure: A Serial Magnetic Resonance Imaging Study with Ex Vivo and Postmortem Confirmation , 2011, Biological Psychiatry.

[2]  H. Stefánsson,et al.  Maternally derived microduplications at 15q11-q13: implication of imprinted genes in psychotic illness. , 2011, The American journal of psychiatry.

[3]  Ronald Pierson,et al.  Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. , 2011, Archives of general psychiatry.

[4]  Arthur W. Toga,et al.  The contributions of disease and genetic factors towards regional cortical thinning in schizophrenia: The UCLA family study , 2010, Schizophrenia Research.

[5]  Alan R. Mardinly,et al.  EphB-Mediated Degradation of the RhoA GEF Ephexin5 Relieves a Developmental Brake on Excitatory Synapse Formation , 2010, Cell.

[6]  S. Djurovic,et al.  A genome-wide association study of bipolar disorder in Norwegian individuals, followed by replication in Icelandic sample. , 2010, Journal of affective disorders.

[7]  Elvira Bramon,et al.  Gene variants associated with schizophrenia in a Norwegian genome-wide study are replicated in a large European cohort. , 2010, Journal of psychiatric research.

[8]  R. Kahn,et al.  Cigarette smoking and progressive brain volume loss in schizophrenia , 2010, European Neuropsychopharmacology.

[9]  I. Melle,et al.  Cortical Thickness and Subcortical Volumes in Schizophrenia and Bipolar Disorder , 2010, Biological Psychiatry.

[10]  O. Andreassen,et al.  Investigating relationships between cortical thickness and cognitive performance in patients with schizophrenia and healthy adults , 2010, Psychiatry Research: Neuroimaging.

[11]  N. C. Schanen,et al.  The comorbidity of autism with the genomic disorders of chromosome 15q11.2-q13 , 2010, Neurobiology of Disease.

[12]  I. Deary,et al.  The neuroscience of human intelligence differences , 2010, Nature Reviews Neuroscience.

[13]  A. Bertelsen,et al.  Severe mental disorders in offspring with 2 psychiatrically ill parents. , 2010, Archives of general psychiatry.

[14]  Alan R. Mardinly,et al.  The Angelman Syndrome Protein Ube3A Regulates Synapse Development by Ubiquitinating Arc , 2010, Cell.

[15]  G. Miller,et al.  Psychiatry. Proposed revisions to psychiatry's canon unveiled. , 2010, Science.

[16]  B. Crespi,et al.  Comparative genomics of autism and schizophrenia , 2010, Proceedings of the National Academy of Sciences.

[17]  Sami Yamin,et al.  Are we using excessive neuroleptics? An argument for systematic neuroleptic dose reduction in stable patients with schizophrenia with specific reference to clozapine , 2010, International review of psychiatry.

[18]  A. Dale,et al.  Distinct genetic influences on cortical surface area and cortical thickness. , 2009, Cerebral cortex.

[19]  Pall I. Olason,et al.  Common variants conferring risk of schizophrenia , 2009, Nature.

[20]  P. Visscher,et al.  Common polygenic variation contributes to risk of schizophrenia and bipolar disorder , 2009, Nature.

[21]  Jianxin Shi,et al.  Common variants on chromosome 6p22.1 are associated with schizophrenia , 2009, Nature.

[22]  A. Meyer-Lindenberg,et al.  Widespread reductions of cortical thickness in schizophrenia and spectrum disorders and evidence of heritability. , 2009, Archives of general psychiatry.

[23]  Nick Craddock,et al.  Psychosis genetics: modeling the relationship between schizophrenia, bipolar disorder, and mixed (or "schizoaffective") psychoses. , 2009, Schizophrenia bulletin.

[24]  S. Cichon,et al.  Neural Mechanisms of a Genome-Wide Supported Psychosis Variant , 2009, Science.

[25]  Alan C. Evans,et al.  Effects of the Val158Met catechol-O-methyltransferase polymorphism on cortical structure in children and adolescents , 2009, Molecular Psychiatry.

[26]  Tyrone D. Cannon,et al.  Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study , 2009, The Lancet.

[27]  Andrew D. Johnson,et al.  SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap , 2008, Bioinform..

[28]  G. Kirov,et al.  Phenotypic variations on the theme of CNVs , 2008, Nature Genetics.

[29]  Thomas W. Mühleisen,et al.  Large recurrent microdeletions associated with schizophrenia , 2008, Nature.

[30]  C. Spencer,et al.  Identification of loci associated with schizophrenia by genome-wide association and follow-up , 2008, Nature Genetics.

[31]  D. Geschwind,et al.  Advances in autism genetics: on the threshold of a new neurobiology , 2008, Nature Reviews Genetics.

[32]  Joshua M. Korn,et al.  Association between microdeletion and microduplication at 16p11.2 and autism. , 2008, The New England journal of medicine.

[33]  N. Schork,et al.  Advances in endophenotyping schizophrenia , 2008, World psychiatry : official journal of the World Psychiatric Association.

[34]  A. Frigessi,et al.  Regional thinning of the cerebral cortex in schizophrenia: Effects of diagnosis, age and antipsychotic medication , 2008, Schizophrenia Research.

[35]  A. Holland,et al.  The phenomenology and diagnosis of psychiatric illness in people with Prader–Willi syndrome , 2008, Psychological Medicine.

[36]  André J. W. van der Kouwe,et al.  Detection of cortical thickness correlates of cognitive performance: Reliability across MRI scan sessions, scanners, and field strengths , 2008, NeuroImage.

[37]  Michael F. Green,et al.  Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia. , 2007, Archives of general psychiatry.

[38]  Arthur W Toga,et al.  Relationships between IQ and regional cortical gray matter thickness in healthy adults. , 2007, Cerebral cortex.

[39]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[40]  Deanna Greenstein,et al.  Cortical brain development in nonpsychotic siblings of patients with childhood-onset schizophrenia. , 2007, Archives of general psychiatry.

[41]  A. Sampson,et al.  Effect of Chronic Exposure to Antipsychotic Medication on Cell Numbers in the Parietal Cortex of Macaque Monkeys , 2007, Neuropsychopharmacology.

[42]  T. van Amelsvoort,et al.  Genetic variation in COMT and PRODH is associated with brain anatomy in patients with schizophrenia , 2007, Genes, brain, and behavior.

[43]  Anders M. Dale,et al.  Regional cortical thickness matters in recall after months more than minutes , 2006, NeuroImage.

[44]  John H. Gilmore,et al.  Apoptotic mechanisms and the synaptic pathology of schizophrenia , 2006, Schizophrenia Research.

[45]  Zhuoxin Sun,et al.  The Influence of Chronic Exposure to Antipsychotic Medications on Brain Size before and after Tissue Fixation: A Comparison of Haloperidol and Olanzapine in Macaque Monkeys , 2005, Neuropsychopharmacology.

[46]  R. Woods,et al.  Cortical Thinning in Cingulate and Occipital Cortices in First Episode Schizophrenia , 2005, Biological Psychiatry.

[47]  J. Lieberman,et al.  Antipsychotic drug effects on brain morphology in first-episode psychosis. , 2005, Archives of general psychiatry.

[48]  A. Meyer-Lindenberg,et al.  The Brain-Derived Neurotrophic Factor val66met Polymorphism and Variation in Human Cortical Morphology , 2004, The Journal of Neuroscience.

[49]  P. Sullivan,et al.  Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. , 2003, Archives of general psychiatry.

[50]  Marianna D. Eddy,et al.  Regionally localized thinning of the cerebral cortex in schizophrenia , 2003, Schizophrenia Research.

[51]  Suzanne E. Welcome,et al.  Mapping cortical change across the human life span , 2003, Nature Neuroscience.

[52]  R. Kahn,et al.  Brain volume changes in first-episode schizophrenia: a 1-year follow-up study. , 2002, Archives of general psychiatry.

[53]  J. Volavka,et al.  Optimal Dosing of Atypical Antipsychotics in Adults: A Review of the Current Evidence , 2002, Harvard review of psychiatry.

[54]  R. Kahn,et al.  Brain morphology in antipsychotic-naïve schizophrenia: A study of multiple brain structures , 2002, British Journal of Psychiatry.

[55]  A. Holland,et al.  Psychotic illness in people with Prader Willi syndrome due to chromosome 15 maternal uniparental disomy , 2002, The Lancet.

[56]  R. Murray,et al.  Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. , 1999, Archives of general psychiatry.

[57]  L. DeLisi,et al.  Association of brain structural change with the heterogeneous course of schizophrenia from early childhood through five years subsequent to a first hospitalization , 1998, Psychiatry Research: Neuroimaging.

[58]  Tyrone D. Cannon,et al.  A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures. , 1998, Archives of general psychiatry.

[59]  K Kroenke,et al.  Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. , 1994, JAMA.

[60]  I. Melle,et al.  Neurocognitive dysfunction in bipolar and schizophrenia spectrum disorders depends on history of psychosis rather than diagnostic group. , 2011, Schizophrenia bulletin.

[61]  Daniel Mathalon,et al.  A genome-wide association study of schizophrenia using brain activation as a quantitative phenotype. , 2009, Schizophrenia bulletin.

[62]  E. Cantor-Graae,et al.  Schizophrenia and migration: a meta-analysis and review. , 2005, The American journal of psychiatry.

[63]  Tyrone D. Cannon,et al.  The genetic epidemiology of schizophrenia in a Finnish twin cohort. A population-based modeling study. , 1998, Archives of general psychiatry.

[64]  J. Murray,et al.  The Global Burden of Disease , 1996 .